Exagen, Inc. (XGN)
7.09
+1.28
(+22.03%)
USD |
NASDAQ |
Nov 09, 16:00
7.12
+0.03
(+0.42%)
After-Hours: 18:15
Exagen Gross Profit (Annual) : 38.80M for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 38.80M |
| December 31, 2024 | 33.11M |
| December 31, 2023 | 29.46M |
| December 31, 2022 | 21.35M |
| December 31, 2021 | 27.71M |
| December 31, 2020 | 25.42M |
| December 31, 2019 | 21.58M |
| Date | Value |
|---|---|
| December 31, 2018 | 16.92M |
| December 31, 2017 | 12.48M |
| December 31, 2015 | 8.205M |
| December 31, 2014 | 4.558M |
| December 31, 2013 | 0.011M |
| December 31, 2012 | -1.262M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Myriad Genetics, Inc. | 576.60M |
| BioRestorative Therapies, Inc. | 0.1259M |
| CareDx, Inc. | 253.96M |
| Natera, Inc. | 1.491B |
| Sera Prognostics, Inc. | -0.907M |